|
05 May 2010 |
Osiris Resumes Enrollment in Stem Cell Trial for Crohn's Disease Following Positive Interim Analysis
|
|
05 May 2010 |
MDRNA, Inc. Reports Novel Target Specificity Characteristics of Its Proprietary UsiRNA Technology for RNAi-based Therapeutics
|
|
05 May 2010 |
Novocell Becomes ViaCyte, Inc., as it Accelerates Pre-Clinical Development of a Stem Cell Derived Treatment for Diabetes
|
|
04 May 2010 |
NOXXON Announces the Completion of the First-in-Human Clinical Trial with Spiegelmer NOX-A12
|
|
03 May 2010 |
StemCells, Inc.'s Phase I Batten Trial Data Featured at American Association of Neurological Surgeons Annual Meeting
|
|
30 Apr 2010 |
Biocancell Receives U.S. FDA Approval to Continue Phase IIb Superficial Bladder Cancer Clinical Trial and Interim Results
|
|
30 Apr 2010 |
MESOBLAST COMPLETES ENROLMENT FOR FIRST SPINAL FUSION TRIAL
|
|
29 Apr 2010 |
TXCELL ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM THE PHASE I/IIA CLINICAL TRIAL OF OVASAVE IN CROHN’S DISEASE
|
|
28 Apr 2010 |
MDRNA, Inc. Announces Combinations of UsiRNAs in Proprietary DiLA2 Delivery Technology Show Improved Efficacy in Bladder Cancer Model
|
|
28 Apr 2010 |
Ceregene has Initiated a New Phase 1/2 Trial Of CERE-120 for Parkinson's Disease
|
|
28 Apr 2010 |
Celladon Corp. Announces that MYDICAR® Meets Primary Endpoint in Phase 2 Trial for Treatment of Advanced Heart Failure
|
|
27 Apr 2010 |
Pluristem Therapeutics Announces Interim Top-Line Results From PLX--PAD Clinical Trials
|
|
27 Apr 2010 |
Alnylam Publishes Results from Phase II GEMINI Trial with ALN-RSV01
|
|
26 Apr 2010 |
Santaris Pharma A/S Advances RNA-Targeted Drug Development Candidate Against PCSK9, an Important New Target for the Treatment of High Cholesterol
|
|
26 Apr 2010 |
Ophthotech Enrolls Its First Patient in a Randomized, Controlled Phase II Study of E10030 in Macular Degeneration
|
|
22 Apr 2010 |
Geron Gives Five Presentations on Telomerase Inhibitor Imetelstat at the AACR Annual Meeting
|
|
21 Apr 2010 |
Silence Therapeutics and AstraZeneca Extend siRNA Delivery Collaboration
|
|
20 Apr 2010 |
Alnylam and Collaborators Demonstrate Regression of Pathogenic Transthyretin (TTR) Amyloid Deposits Following Treatment with an RNAi Therapeutic in an Animal Model of TTR-Mediated Amyloidosis (ATTR)
|
|
20 Apr 2010 |
Intravenous Administration of Endometrial Regenerative Cells (ERC) Induces Benefit in Heart Failure Patient
|
|
19 Apr 2010 |
Positive Interim Results for JX-594 Randomized Phase 2 Liver Cancer Trial Presented at Major International Conference (EASL)
|
|
15 Apr 2010 |
Idera Pharmaceuticals Announces Positive Phase 1 Data of IMO-2125 in Null Responder HCV Patients at EASL 2010
|
|
15 Apr 2010 |
Regulus Therapeutics Presents New Pre-clinical Data on microRNA Therapeutics for Diabetes
|
|
15 Apr 2010 |
Cequent Begins Chronic Toxicology Study with CEQ508, Lead Oncology tkRNAi Drug Candidate; Also Initiates First NHP Toxicology Study of Novartis-Optioned IBD Drug Candidate
|
|
13 Apr 2010 |
Benitec Limited (ASX:BLT) T Cell HIV Trial Open For Recruitment
|
|
13 Apr 2010 |
Jennerex Completes Patient Enrollment in Phase 1 Trial for Intravenous Administration of JX-594
|
